Navigation Links
Physicians Who Treat Obesity Respond to the News of Bubba Smith's Overdose
Date:11/10/2011

DENVER, Nov. 10, 2011 /PRNewswire/ -- The American Society of Bariatric Physicians (ASBP) is sad to learn of the death of Bubba Smith.  Our condolences go out to his family, friends and fans.  The recent news reports regarding the fact that the medication phentermine was a contributing factor to his death are concerning and bring to the forefront the importance of using such medications as prescribed.

While the specific details of Bubba Smith's overdose have not been released, we feel that it is important to understand phentermine's role in weight loss.  Phentermine is a safe and effective medication that can assist in the treatment of the chronic disease of obesity when prescribed in conjunction with a comprehensive weight loss program that includes proper diet, exercise, and behavior modification.  

In most cases, the risk of not treating obesity far outweighs the risk of adverse events from taking phentermine.  It is the job of the bariatric physician to identify and evaluate those rare circumstances in which the risk of taking phentermine is higher than leaving the obesity untreated.  In Bubba Smith's case, it appears from media reports that he suffered from heart disease, atherosclerosis and uncontrolled hypertension, and the ASBP expects these diseases to be taken into consideration when phentermine is prescribed.  

Possible adverse effects from phentermine include high blood pressure, rapid heart rate, palpitations, dry mouth and insomnia.  Most often these effects are minor and the medication is well tolerated as long as it is taken as prescribed.  However, appropriate monitoring by an expert physician is necessary to ensure that the medication is safe to use.  For further information about phentermine please speak with your healthcare provider.

About the ASBP

Founded in 1950, the ASBP is the oldest medical association dedicated to the non-surgical treatment of obesity and associated diseases. The ASBP is a collaborative organization that provides its members practical information and business tools to implement a successful medical bariatric practice. For more information about the ASBP, visit www.asbp.org.


'/>"/>
SOURCE American Society of Bariatric Physicians
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mayo Clinic Physicians Report Findings from Research on Sleep Disorders
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
4. Physicians Will Benefit from Medical Software Advice Website
5. Physicians Reconsider Implications of Enhance Trial
6. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
7. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
8. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
9. Physicians Health Study II Finds No Magic Bullet for Preventing Cardiovascular Disease
10. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
11. Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 28, 2017 , ... Children and adolescents who enter the ... children in the general population. That’s because foster care is designed to protect ... While no fault of their own, youth who have experienced trauma often have ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... could substantially improve drug safety and minimize the cost of development. In this ... channel inhibition using cell lines and for cardiac toxicity using induced pluripotent stem ...
(Date:4/28/2017)... Abilene, Texas (PRWEB) , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... says, reveals which name the Creator responds to and which He does not. Yisrayl ... to believe which one is the true name, but he says with a little Scripture, ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to ... ERP expert that specializes in long-term care, Brooke Grove now has the capability ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a ... he has leant his presence to an educational purpose as the host of the ... one being cancer. In a recent episode, the series focuses on thyroid cancer. , ...
Breaking Medicine News(10 mins):